Eqis Capital Management, Inc. Repligen Corp Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $146,725 - $191,128	-1,060 Reduced 20.61%	4,083 $577,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $31,314 - $40,214	-203 Reduced 3.8%	5,143 $865,000
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $27,124 - $36,833	167 Added 3.22%	5,346 $905,000
Q3 2022 Oct 24, 2022	BUY	$160.42 - $256.21 $18,127 - $28,951	113 Added 2.23%	5,179 $969,000
Q2 2022 Aug 08, 2022	SELL	$140.68 - $188.02 $171,207 - $228,820	-1,217 Reduced 19.37%	5,066 $822,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $131,208 - $209,979	814 Added 14.88%	6,283 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $318,400 - $391,548	-1,286 Reduced 19.04%	5,469 $1.45 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $470,759 - $783,615	2,417 Added 55.72%	6,755 $1.95 Million
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $131,037 - $174,550	-790 Reduced 15.41%	4,338 $866,000
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $195,160 - $244,813	1,082 Added 26.74%	5,128 $997,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $25,765 - $35,943	174 Added 4.49%	4,046 $775,000
Q3 2020 Nov 10, 2020	SELL	$122.51 - $158.27 $28,422 - $36,718	-232 Reduced 5.65%	3,872 $571,000
Q2 2020 Aug 10, 2020	BUY	$94.33 - $140.48 $31,883 - $47,482	338 Added 8.98%	4,104 $507,000
Q1 2020 May 12, 2020	BUY	$84.96 - $109.14 $101,527 - $130,422	1,195 Added 46.48%	3,766 $382,000
Q4 2019 Jan 24, 2020	SELL	$73.84 - $93.08 $227,796 - $287,151	-3,085 Reduced 54.54%	2,571 $238,000
Q3 2019 Nov 05, 2019	SELL	$76.65 - $95.51 $48,136 - $59,980	-628 Reduced 9.99%	5,656 $434,000
Q2 2019 Jul 18, 2019	BUY	$54.2 - $85.95 $340,592 - $540,109	6,284 New	6,284 $540,000
Q4 2017 Jan 25, 2018	SELL	$32.53 - $38.92 $260,890 - $312,138	-8,020 Closed	0 $0
Q3 2017 Oct 03, 2017	BUY	$36.98 - $46.06 $296,579 - $369,401	8,020	8,020 $307,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.17 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$990 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$781 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$251 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$220 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account